After introduction in Germany and the USA

Bayer launches transparency register on external research collaborations in Switzerland

Jumbotron Explorer

Leverkusen / Zurich, February 7, 2024 - Bayer is launching the Bayer Science Collaboration Explorer (BSCE) transparency register in Switzerland today. In the public database, the company provides information on its scientific collaborations and new contracts with universities, public research institutions and individuals. The Explorer is part of Bayer's commitment to strengthen trust in scientific innovations, processes and research and development activities.

For each new contract-based scientific collaboration with a university, public research organization or individual, the following core information is published in the BSCE: name and location of the institution/individual, type of agreement (e.g. "research contract"), category of subject matter (e.g. "oncology" or "digital agriculture"), financial size, effective date, Bayer division involved.

Research companies such as Bayer regularly collaborate with scientific organizations to find suitable solutions to challenges in the health and agricultural sectors. However, such collaborations are sometimes viewed skeptically, especially company-funded partnerships. Bayer wants to promote trust in science by providing comprehensive transparency about its research collaborations.

"The launch of the Bayer Science Collaboration Explorer in Switzerland underlines our commitment to transparency," says Matthias Berninger, Executive Vice President Public Affairs, Science & Sustainability at Bayer. "We have developed the industry-wide unique transparency register together with our external stakeholders – science organizations, associations and non-governmental organizations. Their positive feedback encourages us to work together to promote the trust in innovation that our society needs."

The Explorer is one of Bayer's twelve transparency initiatives. In addition to the research collaborations, the public has access to information from various areas – from clinical studies to safety studies on Bayer's products in the crop protection sector or individual health to lobbying expenditures.

Further information on the Bayer Science Collaboration Explorer can be found on the continuously updated website bayer.com/bsce.

Contact

Nicole Borel
Phone: +41 79 274 70 79
Email: nicole.borel@bayer.com 
 

Bayer is a global company with core competencies in the life science fields of health and nutrition. With its products and services, the company aims to benefit people and protect the environment by helping to solve the fundamental challenges of a steadily growing and aging world population. Bayer is committed to making a significant contribution to sustainable development through its business activities. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality worldwide. In fiscal year 2022, the Group generated sales of EUR 50.7 billion with around 101,000 employees. Adjusted for special items, expenditure on research and development amounted to EUR 6.2 billion. Further information can be found on the Internet at bayer.com/bsce.

This press release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports. These reports are available on the Bayer website www.bayer.com. The company assumes no obligation to update these forward-looking statements or to conform them to future events or developments.